These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 21330685)

  • 1. Expanding knowledge and opportunity in pharmacy.
    Wehrli A
    Am J Health Syst Pharm; 2011 Mar; 68(5):426-32. PubMed ID: 21330685
    [No Abstract]   [Full Text] [Related]  

  • 2. Global opportunity: Pharmacists working together to improve patient care.
    Ivey MF
    Am J Health Syst Pharm; 2019 Jun; 76(12):869-872. PubMed ID: 31506702
    [No Abstract]   [Full Text] [Related]  

  • 3. Richly blessed or simply lucky: Lessons learned on the road to Remington.
    Maine LL
    J Am Pharm Assoc (2003); 2019; 59(4):e8-e11. PubMed ID: 31296327
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacy practice around the world.
    Lutz EM; Rovers J; Mattingly J; Reed BN
    J Am Pharm Assoc (2003); 2009; 49(1):4-11. PubMed ID: 19196590
    [No Abstract]   [Full Text] [Related]  

  • 5. The infancy of an international pediatric pharmacy network.
    Knoppert D; Arenas-Lopez S; McArtney R
    Paediatr Drugs; 2008; 10(2):71-3. PubMed ID: 18345716
    [No Abstract]   [Full Text] [Related]  

  • 6. Advocacy: the essential competence.
    Boyle CJ
    J Am Pharm Assoc (2003); 2009; 49(3):364, 366. PubMed ID: 19443317
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of a professional organization in promoting and conducting research: the Lebanese Order of Pharmacists' experience.
    Hallit S; Sacre H; Salameh P
    Int J Pharm Pract; 2019 Jun; 27(3):330-331. PubMed ID: 31111986
    [No Abstract]   [Full Text] [Related]  

  • 8. Need for greater continuity of care.
    Manasse HR; Menighan TE
    Am J Health Syst Pharm; 2011 Mar; 68(6):476, 478. PubMed ID: 21378293
    [No Abstract]   [Full Text] [Related]  

  • 9. 2017 Prescott Lecture: Bridging the intersection between pharmacy, advocacy, and value-based care.
    Wagner A
    J Am Pharm Assoc (2003); 2017; 57(4):439-441. PubMed ID: 28712462
    [No Abstract]   [Full Text] [Related]  

  • 10. Achieving recognition as patient-centered care providers: we are our own best advocates.
    Cooke RL; Lipowski E; Magness JW
    J Am Pharm Assoc (2003); 2013; 53(3):234, 236-8. PubMed ID: 23699671
    [No Abstract]   [Full Text] [Related]  

  • 11. APhA2017 House of Delegates: Opportunities for collaboration: The impact of science and research on pharmacy practice.
    Urick B
    J Am Pharm Assoc (2003); 2017; 57(4):429-430. PubMed ID: 28712459
    [No Abstract]   [Full Text] [Related]  

  • 12. Advancing pharmacy practice through policies: development, debate, and consensus in the APhA House of Delegates.
    Boyle CJ; Lipowski EE; Vernon V
    J Am Pharm Assoc (2003); 2011; 51(4):462-5. PubMed ID: 21752766
    [No Abstract]   [Full Text] [Related]  

  • 13. ASHP guidelines on home infusion pharmacy services.
    Petroff BJ; Filibeck D; Nowobilski-Vasilios A; Olsen RS; Rollins CJ; Johnson C
    Am J Health Syst Pharm; 2014 Feb; 71(4):325-41. PubMed ID: 24481158
    [No Abstract]   [Full Text] [Related]  

  • 14. Medication risk mitigation matrix: A pharmaceutical care opportunity for precision medication.
    Knowlton CH
    J Am Pharm Assoc (2003); 2015; 55(4):354-8. PubMed ID: 25820799
    [No Abstract]   [Full Text] [Related]  

  • 15. Oh, the places they can go: response to APhA-ASHP report on concerns about accelerating expansion of pharmacy education.
    Teagarden RJ; Furgieule T
    J Am Pharm Assoc (2003); 2011; 51(3):327-8. PubMed ID: 21555282
    [No Abstract]   [Full Text] [Related]  

  • 16. [Promotion of Pharmaceutical Care and Sciences: Focus of the Japanese Society of Pharmaceutical Health Care and Sciences].
    Sasaki H
    Yakugaku Zasshi; 2019; 139(3):405-410. PubMed ID: 30828019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Report of the APhA and APhA-ASP Houses of Delegates.
    Bzowyckyj A; Oestreich J; Kirk LM
    J Am Pharm Assoc (2003); 2015; 55(4):340, 342-4, 346-7. PubMed ID: 26161477
    [No Abstract]   [Full Text] [Related]  

  • 18. FIP's response to the COVID-19 pandemic: Global pharmacy rises to the challenge.
    Sousa Pinto G; Hung M; Okoya F; Uzman N
    Res Social Adm Pharm; 2021 Jan; 17(1):1929-1933. PubMed ID: 33317767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Residency requirement for pharmacists providing direct patient care.
    Nahata MC
    Ann Pharmacother; 2010 Nov; 44(11):1822-5. PubMed ID: 20923948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncology pharmacy practice as a model for international collaborations.
    Goldspiel BR
    Am J Health Syst Pharm; 2012 Jun; 69(11):951-7. PubMed ID: 22610027
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.